Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Neeraja Tillu is a rising leader in urologic oncology, whose work is redefining the surgical management of bladder and prostate cancers. Her primary research focuses on advancing robotic-assisted surgery, particularly through the refinement of radical cystectomy and intracorporeal neobladder urinary diversion—a technically demanding procedure that restores patients’ quality of life after bladder removal. Her landmark 2023 paper, “Atlas of Intracorporeal Orthotopic Neobladder Techniques,” has already garnered 29 citations, serving as an essential guide for surgeons worldwide. Dr. Tillu has also pioneered the robotic repair of ureteroenteric strictures, a common and debilitating complication after cystectomy, demonstrating improved outcomes through a detailed video-based technique endorsed by the European Robotic Urology Section. Her decade-long, single-surgeon study comparing open versus robotic cystectomy (2025) provides critical long-term data on perioperative, oncological, and functional outcomes. Beyond surgery, she is integrating genomic classifiers and circulating tumor DNA analysis to predict lymph node metastasis, pushing the field toward personalized, biomarker-driven treatment. With a growing portfolio of high-impact publications, Dr. Tillu is shaping the future of minimally invasive urologic oncology.